NEW YORK (GenomeWeb) – The Parkinson's Institute and Clinical Center announced on Friday a collaboration with Germany's Centogene on panel-based genetic screening for a US patient cohort.

Under the partnership, patients will be screened using a large, customized panel to characterize genetic variants associated with development and treatment of Parkinson's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.